A Personal Story: The Need for Medicare Coverage of Continuous Glucose Monitors (CGM)

Diabetes technologies have the potential to transform the care of people with diabetes. The continuous glucose monitor (CGM) has been shown to improve glucose control—preventing dangerous high and low blood sugars—and is recommended by national diabetes clinical guidelines and covered by private health plans. However, Medicare does not yet cover CGM devices, denying Americans age […]

JDRF 2015 Children’s Congress application site remains open

JDRF is pleased to announce that applications for JDRF 2015 Children’s Congress are currently being accepted. JDRF Children’s Congress, our highest profile advocacy event, is held every two years in the nation’s capital. Next year’s event will take place from July 13 to 15, 2015. It will include more than 150 children, ages 4 to […]

CGM-Medicare Bill Introduced in House

JDRF Commends U.S. Representatives Reed, DeGette and Whitfield for Introducing Continuous Glucose Monitor (CGM) Coverage Legislation JDRF commends U.S. Representatives Tom Reed (R-NY), Diana DeGette (D-CO) and Ed Whitfield (R-KY) for introducing legislation, H.R. 5644, the ‘Medicare CGM Access Act of 2014,’ calling for continuous glucose monitor (CGM) coverage by Medicare. This legislation (which now […]

Volunteer Spotlight: Martin Gilmore

Volunteer Spotlight: Martin Gilmore

Martin Gilmore and his wife Susan were Co-Chairs of the Piedmont Triad Hope Gala in 2013. Martin Gilmore is a focused professional and dedicated father who is “in the game” until JDRF has accomplished its vision of creating a world without type 1 diabetes (T1D). Why JDRF? Martin’s daughter, Margaret, was diagnosed with T1D in 2007 […]

Boost JDRF research progress at Walgreens and Duane Reade

Get your flu shot at your community Walgreens or Duane Reade and JDRF will receive money for T1D research From September 1 to November 30, Walgreens will donate $1 to JDRF per flu shot to our supporters — up to a total of $100,000! Download and bring in this JDRF promotional flyer on your visit. […]

JDRF Partner ViaCyte to Immediately Initiate Type 1 Diabetes Clinical Trial

Updated Sept. 18, 2014 JDRF’s partner ViaCyte recently announced the U.S. Food and Drug Administration (FDA) is allowing them to move forward with a clinical trial of its innovative type 1 diabetes (T1D) encapsulated cell replacement therapy called VC-01™ product candidate. The company plans to immediately initiate the first ever clinical evaluation of a stem […]

Volunteer Spotlight: Debbie Newman

A Generational Force In 1983 when Debbie Newman and her husband Dr. Stephen Newman first received then five year old daughter Emile’s type one diabetes (T1D) diagnosis, they were frightened but also familiar with the lifestyle. “T1D care has changed dramatically since I watched my father sterilize his glass syringes by boiling them in a […]

Volunteer Spotlight: Sarah Lucas

Like many families when first faced with type 1 diabetes (T1D), Sarah Lucas and her husband Don found themselves in unfamiliar waters, anxious and overwhelmed when their daughter Mary was diagnosed in 1998. “We weren’t certain what to do, but we knew we had to do something that would help us gain a foothold, and […]

Top 10 Advances in T1D Research

JDRF-supported progress in fiscal year 2014 JDRF sets ambitious goals for progress in type 1 diabetes (T1D) research each year because our supporters inspire us to aim higher. We invite you to read about the real impact our strategic plan is making and hope you are as inspired as we are as each of these […]